Get the app
USHealthcare

IQVIA Holdings Inc (IQV)

US · Healthcare · Diagnostics & Research

$269.44+0.23%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$4.37B
Revenue YoY
+8.7%
Net profit
$256.0M
Profit YoY
-3.8%
EPS
$2.75
EPS estimate
$2.72
Net margin
5.9%

EPS came in at 2.75 against a street estimate of 2.72 — a beat of 1.1%.

Key statistics

Market cap
$43.09B
P/E
32.0
Forward P/E
18.0
P/B
6.98
Book value
$37.49
EPS (TTM)
$8.17
52-week high
$271.80
52-week low
$154.50
50-day MA
$235.22
200-day MA
$202.68
Beta
1.19

Analyst view

Analysts rate IQVIA Holdings Inc a buy (16 buy, 7 hold, 0 sell out of 23) with an average price target of $276.28.

From the latest earnings call · 2026-07-28

CONFIDENT IQV beat Q2 guidance across revenue, EBITDA, EPS. Organic growth accelerated to 6% YoY (3x prior year). R&D bookings surged 19% with 1.22 book-to-bill. Raised FY26 guidance on stronger execution and market demand. Q2 2026 Call did not break out geographic segment performance by region. Analysts pressed on bookings quality (any one-time items), market vs. execution contribution to guidance raise, and competitive positioning on price vs. AI. Management emphasized broad-based, normal-range bookings, improving RFP flows and win rates driven by AI/capabilities, and rates set upfront in partnerships—price not primary RFP lever. 2026-07-28…

Full summary in the app.

Shareholding

Insiders
1.09%
Institutions
103.42%

Largest institutional holders

FundStake
BlackRock Inc9.13%
Harris Associates L.P.7.40%
Vanguard Capital Management, LLC6.70%
Vanguard Portfolio Management, LLC4.60%
State Street Corp4.54%
JPMorgan Chase & Co3.29%
Artisan Partners Limited Partnership2.88%
Geode Capital Management, LLC2.71%

Recent filings & reports

DocumentDate
Company announcement · Q3 2026
IQVIA HOLDINGS INC. - 8-K SUMMARY HEADLINE NUMBERS • Company (via subsidiary IQVIA Inc.) raising $2,000,000,000 in gross proceeds through senior not
2026-09-09
Quarterly report · Q2 2026
IQVIA HOLDINGS INC. – FORM 10-Q SUMMARY Quarter Ended June 30, 2026 --- HEADLINE NUMBERS • Total revenues Q2 2026: $4,368 million (up 8.7% vs. Q2 2
2026-07-28
Results announced · Q3 2026
IQVIA Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Revenue: $4,368 million, up 8.7% year-over-year; first-half 2026 revenue $8,519 million, up 8.6% •
2026-07-28
Material agreement · Q2 2026
IQVIA HOLDINGS INC. - 8-K SUMMARY HEADLINE NUMBERS • Company issued €950,000,000 in senior notes on June 11, 2026 • Notes carry 4.625% annual intere
2026-06-11
Company announcement · Q2 2026
IQVIA HOLDINGS INC. - 8-K SUMMARY HEADLINE NUMBERS • IQVIA Inc. (subsidiary of IQVIA Holdings Inc.) priced €950,000,000 in senior notes due 2033 • I
2026-06-04
Company announcement · Q2 2026
IQVIA HOLDINGS INC. – 8-K SUMMARY HEADLINE NUMBERS • Company announced plans to raise €950,000,000 (approximately $950 million USD equivalent) in gr
2026-06-03
Quarterly report · Q1 2026
IQVIA HOLDINGS INC. - Q1 2026 SUMMARY HEADLINE NUMBERS • Revenue: $4,151 million for Q1 2026, up 8.4% from $3,829 million in Q1 2025 • Net income at
2026-05-05
Proxy statement · Q2 2026
IQVIA HOLDINGS INC. — 2026 PROXY SUMMARY CEO COMPENSATION • Ari Bousbib (Chairman and CEO) 2025 total compensation: $20.8 million (exact figure from
2026-02-27

Readable in the app.

Deals & corporate news

AnnouncementDate
Board authorizes additional $2 billion common stock repurchase
IQVIA Holdings Inc. announced on May 7, 2026, that its board of directors authorized an additional $2 billion in stock repurchases under its existing equity repurchase program. This increase
2026-05-07

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for IQVIA Holdings Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.